Table 2.

Pharmacist survey responses

	No. (%) of survey respondents (N = 470)
Completed THN program training
Yes	278 (59.1)
No	119 (25.3)
Was not aware there was a THN training program	73 (15.5)
Did you feel the THN program training was sufficient?
Yes	234 (49.8)
No	47 (10)
Have not completed the THN program training	189 (40.2)
Pharmacists should be screening patients to identify those at risk of opioid overdose
Strongly agree	110 (23.4)
Agree	251 (53.4)
Neutral	76 (16.2)
Disagree	23 (4.9)
Strongly disagree	10 (2.1)
Scale (1 to 5)	3.91 (SD = 0.88)
Pharmacists should be recommending and/or prescribing THN kits for patients at high risk for opioid overdose
Strongly agree	152 (32.3)
Agree	223 (47.4)
Neutral	56 (11.9)
Disagree	26 (5.5)
Strongly disagree	13 (2.8)
Scale (1 to 5)	4.01 (SD = 0.96)
How confident are you in your ability to provide education/counsel on the THN kits?
Very confident	42 (8.9)
Confident	154 (32.8)
Somewhat confident	124 (26.4)
Not very confident	93 (19.8)
Not at all confident	57 (12.1)
Scale (1 to 5)	3.07 (SD = 1.17)
How willing are you to participate in the THN program?
Extremely willing	91 (19.4)
Very willing	194 (41.3)
Moderately willing	107 (22.8)
A little willing	51 (10.9)
Not at all willing	27 (5.7)
Scale (1 to 5)	3.58 (SD = 1.09)
How comfortable are you in engaging in conversation on the THN program with a patient?
Very comfortable	50 (10.6)
Comfortable	151 (31.2)
Somewhat comfortable	137 (29.1)
Slightly comfortable	74 (15.7)
Not at all comfortable	58 (12.3)
Scale (1 to 5)	3.13 (SD = 1.18)
Are you already participating in the THN program?
Yes	218 (46.4)
No	252 (53.6)
Do you or your pharmacy currently participate in other harm reduction initiatives?
Yes	341 (72.6)
No	58 (12.3 )
Not applicable	71 (15.1)

THN, Take Home Naloxone; SD, standard deviation.